foxo4 dri peptide senolytic human trial FOXO4-DRI UK | Research The disordered p53 transactivation domain
The disordered p53 transactivation domain is the target of FOXO4 and the senolytic compound FOXO4 DRI Nature Communications Buy FOXO4 DRI Peptide (Proxofim) 10mg BiotechPeptides FOXO4 DRI FOXO4 p53 Interaction Blocker MedChemExpress foxo4 dri senolytic peptide human trials Buy FOXO4 DRI Peptide (Proxofim) 10mg
Pay in 4 interest-free payments of $6.48 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25



